0000000000160777
AUTHOR
Michael Flynn
showing 4 related works from this author
Partitioning of Aerosol Particles in Mixed-phase Clouds at a High Alpine Site
2007
6 German Aerospace Centre, D-82234, Wessling, Germany * Now at Institute for Atmospheric and Climate Science, ETH Zurich, 8092 Zurich, Switzerland Abstract The partitioning of aerosol particles between the cloud and the interstitial phase (i.e., unactivated aerosol) has been investigated during several Cloud and Aerosol Characterization Experiments (CLACE) conducted in winter and summer 2004 and winter 2005 at the high alpine research station Jungfraujoch (3,580 m altitude, Switzerland). Ambient air was sampled using different inlets in order to determine the scavenged fraction of aerosol particles, F Scav , and of black carbon, F Scav,BC . They denote the fraction of the aerosol volume con…
Microphysical Properties of Ice Crystal Precipitation and Surface-Generated Ice Crystals in a High Alpine Environment in Switzerland
2017
AbstractDuring the Cloud and Aerosol Characterization Experiment (CLACE) 2013 field campaign at the High Altitude Research Station Jungfraujoch, Switzerland, optically thin pure ice clouds and ice crystal precipitation were measured using holographic and other in situ particle instruments. For cloud particles, particle images, positions in space, concentrations, and size distributions were obtained, allowing one to extract size distributions classified by ice crystal habit. Small ice crystals occurring under conditions with a vertically thin cloud layer above and a stratocumulus layer approximately 1 km below exhibit similar properties in size and crystal habits as Antarctic/Arctic diamond …
Single particle characterization of black carbon aerosols at a tropospheric alpine site in Switzerland
2010
The refractory black carbon (rBC) mass, size distribution (190–720 nm) and mixing state in sub-micron aerosols were characterized from late February to March 2007 using a single particle incandescence method at the high alpine research station Jungfraujoch (JFJ), Switzerland (46.33° N, 7.59° E, 3580 m a.s.l.). JFJ is a ground based location, which is at times exposed to continental free tropospheric air. A median mass absorption coefficient (MAC) of 10.2&plusmn;3.2 m<sup>2</sup> g<sup>−1</sup> at &lambda;=630 nm was derived by comparing single particle incandescence measurements of black carbon mass with continuous measurements of absorption coefficient. This…
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)
2018
Abstract Background There are limited treatment options for squamous non-small cell lung cancer (sqNSCLC) and prognosis remains poor. The safety and pharmacokinetics (PK) of nintedanib, a triple angiokinase inhibitor, plus cisplatin/gemcitabine as first-line treatment for advanced sqNSCLC patients, were evaluated. Materials and methods A phase I, dose-escalation study administering drugs in a 21-day cycle: cisplatin (75 mg/m2, Day 1), gemcitabine (1250 mg/m2, Days 1 and 8) and nintedanib (Days 2–7, 9–21) were given for 4–6 cycles, followed by monotherapy until disease progression or adverse events (AEs). Two nintedanib doses were tested, 150 mg twice daily (bid) and 200 mg bid, to determine…